Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions

Bosentan Therapy for Pulmonary Arterial Hypertension

Lewis J. Rubin, David B. Badesch, Robyn J. Barst et al. · New England Journal of Medicine · 2002 · 2.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

Richard N. Channick, G Simonneau, Olivier Sitbon et al. · The Lancet · 2001 · 1.5K citations

Medicine, Pharmacology, Pharmacotherapy +13

Competing interests: none declared.

L. Hirsch · 2006 · 1.4K citations

Public Health, Health Sciences, Epidemiologic Methods +3

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach

D Mukerjee, Deepa George, Bernard Coleiro et al. · Annals of the Rheumatic Diseases · 2003 · 765 citations · Full text

Medicine, Cardiology, Clinical Cardiology +16

Hemodynamics and Survival in Patients With Pulmonary Arterial Hypertension Related to Systemic Sclerosis*

Steven M. Kawut, Darren B. Taichman, Christine Archer‐Chicko et al. · CHEST Journal · 2003 · 423 citations

Medicine, Cardiology, Physiology +12